Internal Medicine · 1997 · 141 citations · 25 references
Life SciencesImmunologyPathologyHypersensitivityImmunopathologyInflammationCytokine BiologyEosinophilic DisordersImmune Cell PhysiologyInflammatory Cell ResponsesInflammatory SignalingChemotactic Cell RecruitmentChemotactic MediatorsChemotactic SignalingConcentrationEosinophil ChemotaxisEosinophil PhysiologyEosinophil RecruitmentEosinophil-mediated Inflammation
The effects of recombinant human (rh) interleukin (IL)-4 or rhIL-13 on survival, and chemotactic activity of human eosinophils were examined. Only rhIL-13 prolonged eosinophil survival in a dose-dependent manner above 3 ng/ml. Eosinophil survival induced by rhIL-13 was inhibited by monoclonal antibodies (mAbs) against IL-3 (p < 0.01) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (p < 0.05), suggesting that rhIL-13 induced IL-3 and GM-CSF production from eosinophils and an autocrine mechanism is responsible for the eosinophil survival. The effects of rhIL-13 on eosinophil chemotactic activity were also examined. rhIL-13 showed chemotactic activity for eosinophils in a dose-dependent manner. Checkerboard analysis revealed that eosinophil migration was dependent on the concentration gradient, confirming that rhIL-13 is a chemotactic factor. rhIL-4 showed no effects. IL-13 may play an important role in the survival and recruitment of eosinophils in allergic diseases.
25
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.
Qutayba Hamid, May Azzawi, Redwan Moqbel et al. · Journal of Clinical Investigation · 1991 · 846 citations · Full text
Life Sciences, Immunology, Pathology +16
S.R. Durham, Veronica Varney, Mikila R. Jacobson et al. · The Journal of Immunology · 1992 · 564 citations